What does digitalization mean in pharmaceutical validation?
Pharmaceutical digitalization is more than scanning paper records or storing Word files in a shared drive. It means designing controlled digital workflows that make regulated work easier to perform, review, approve and inspect. For computerised system validation (CSV), that workflow must connect intended use, requirements, risk, testing, evidence, deviations and final approval.
That is where digital validation software fits. It gives QA, IT, validation and system owners a single environment for managing the validation lifecycle while preserving the controls expected in a GxP environment. The goal is not to remove expert review; it is to remove repetitive administration and make every decision easier to trace.
Why Word and Excel become a digitalization problem
Many pharmaceutical companies start CSV work with familiar tools. A Word document is used for the URS, a spreadsheet for risk assessment, another document for IQ/OQ/PQ, and a manually maintained spreadsheet for the requirements traceability matrix. This can work for a small project, but it creates avoidable risk as systems, sites and reviewers multiply.
- Requirements and test cases can drift apart when the RTM is maintained manually.
- Review comments and approvals are difficult to connect to the final controlled version.
- Repeated copy-and-paste introduces inconsistent terminology and missing references.
- Evidence, deviations and change decisions may be stored in different locations.
- Periodic review and inspection preparation become searches for records rather than a clear workflow.
A digital validation platform addresses these problems by making the relationship between documents, requirements, tests, evidence and approvals explicit. It also creates a repeatable process that can be applied across LIMS, ERP, SCADA, laboratory, manufacturing and quality systems.
What PHARPRO DVS digital validation software provides
URS and validation planning
Start with intended use, business needs, system boundaries, roles and validation strategy in a controlled workspace.
Risk-based CSV
Document GAMP 5-aligned system categorisation, risks, critical functions and a proportionate testing strategy.
IQ, OQ and PQ documentation
Generate structured qualification protocols and reports that reviewers can edit, assess and approve.
Requirements traceability
Connect requirements to risks, test cases and results in an RTM instead of maintaining links manually.
Electronic approvals
Route documents to accountable reviewers with version control, role-based access and attributable approvals.
Audit-ready records
Keep the validation history, changes and audit trail together for inspection readiness and periodic review.
Digital validation software and compliance expectations
Digitalization does not reduce the need for compliance. A pharmaceutical validation platform must support the controls that make electronic records trustworthy. PHARPRO DVS is designed around validation workflows aligned with GAMP 5, FDA 21 CFR Part 11 and EU GMP Annex 11.
GAMP 5 risk-based thinking
Software should help teams focus effort on patient, product and data integrity risks. DVS supports categorisation, risk assessment, criticality decisions and traceability so the rationale for testing is documented rather than assumed.
Electronic records and signatures
Controlled digital validation requires attributable actions, version history, access controls and approval records. These controls help the organisation demonstrate who did what, when and under which approved version.
Human oversight of AI-assisted content
AI can accelerate first drafts and identify relevant document sections, but generated content still requires review by qualified subject matter experts. DVS is intended to support that review—not replace QA accountability or the company's validation decisions.
How to digitalize your CSV process
- Map the current process: identify duplicate entry, manual handoffs, approval delays and evidence scattered across systems.
- Define the intended workflow: agree the lifecycle from URS through validation summary report, including roles and approval points.
- Configure templates and controls: establish document types, risk fields, permissions, naming conventions and review rules.
- Pilot one GxP system: use a representative LIMS, ERP or laboratory system to test the workflow and capture lessons.
- Qualify the platform and train users: document supplier assessment, intended use and user training appropriate to your quality system.
- Scale with governance: monitor metrics, periodic review, change control and continuous improvement across projects.
Digitalization software versus digital validation software
“Digitalization software” is a broad search term that can refer to document management, workflow automation, manufacturing systems or digital transformation consulting. Digital validation software is more specific: it manages the regulated evidence that a GxP computerised system is fit for intended use.
For a pharma company, the strongest solution is one that fits into the wider digital transformation strategy while respecting CSV governance. PHARPRO DVS focuses on the validation lifecycle, so teams can digitalize the work that auditors and inspectors expect to be complete, consistent and traceable.
Frequently asked questions
Is digital validation the same as computerised system validation?
Digital validation is a modern way to plan and manage computerised system validation. The regulated objective remains the same: demonstrate that a system is fit for intended use and remains in a controlled state.
Can DVS be used for a LIMS, ERP or SCADA system?
Yes. The workflow can be adapted to different GxP system types, risk profiles and validation strategies. The project team remains responsible for defining the intended use and required evidence.
Does automation remove the need for QA review?
No. Automation reduces repetitive drafting and administration. Qualified reviewers still assess requirements, risks, test results, deviations and approvals.